Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis.
- DOI
- 10.1016/j.bcp.2026.118353
- Published
- 2026 Nov
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118353,
title = {Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis.},
author = {Lei X and Gong W and Wiesmann-Imilowski N and Jin C and Prajapati S and Guthart A and Klauck SM and Elbadawi M and Shan L and Efferth T and Lu X},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118353},
url = {https://doi.org/10.1016/j.bcp.2026.118353}
}RIS
TY - JOUR TI - Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis. AU - Lei X AU - Gong W AU - Wiesmann-Imilowski N AU - Jin C AU - Prajapati S AU - Guthart A AU - Klauck SM AU - Elbadawi M AU - Shan L AU - Efferth T AU - Lu X PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118353 UR - https://doi.org/10.1016/j.bcp.2026.118353 ER -
APA
X, L., W, G., N, W., C, J., S, P., A, G., SM, K., M, E., L, S., T, E., & X, L. (2026). Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118353
Source records
- pubmed · retrieved 2026-09-26T17:31:59.006Z